Sign in
Progression of diabetic retinopathy in patients treated with 0.2 μg/day
Raymond Iezzi, MD, MS
Updates from the Field
2017
Treatment of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy With Intravitreal Aflibercept Injection: 52-Week Results From PANORAMA
W. Lloyd Clark, MD, FASRS
Annual Meeting Talks
2019
Comparison between ultra-wide field fluorescein angiography and wide angle OCTA on detection of neovascularization in eyes with diabetic retinopathy
Osamu Sawada, MD
On Demand Cases, Courses, and Papers
Category: Diabetic Retinopathy